TESAMORELIN

Tesamorelin is a synthetic growth hormone releasing hormone (GHRH) analog widely studied for its potential role in stimulating natural growth hormone production and supporting metabolic research applications. This research peptide has gained significant attention in studies involving body composition, visceral fat reduction, recovery optimization, muscle preservation, sleep quality, and healthy aging research.

Clinical investigations involving Tesamorelin have demonstrated notable reductions in visceral adipose tissue (VAT) and improvements in certain metabolic markers, particularly in studies focused on fat distribution and growth hormone deficiency-related research. Researchers are also exploring its potential effects on lean muscle retention, cellular recovery pathways, cognitive performance, and overall metabolic function.

Tesamorelin works by signaling the pituitary gland to promote the release of endogenous growth hormone, making it a key compound of interest in peptide and longevity-focused research protocols.

Key Features

• Research-grade GHRH analog peptide
• Studied for growth hormone and metabolic research
• Investigated for visceral fat and body composition support
• Manufactured to strict purity and quality standards
• Intended exclusively for laboratory and investigational use

Disclaimer:
Tesamorelin is intended for laboratory research purposes only. This product is not approved by the FDA for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for medical or veterinary use.